Translational Acceleration and Knowledge Transfer (TRACK) awards
This scheme is currently open for applications.
The deadline is 23:59 Wednesday 6 May 2020.
For further information please contact Sarah Blackmore at email@example.com
About the scheme
Description of the scheme
- TRACK Awards (Translational Acceleration and Knowledge Transfer Awards) will fund initial pilot studies to demonstrate the concept of a proposed solution to a health, clinical or product development need.
- These awards will support health related research projects which have translational/commercial potential but need to undertake an additional, specific piece of work before seeking proof of concept. Projects must demonstrate that they will meet a definable milestone that will enable the project to progress to the next stage.
Award amount and duration
We anticipate that individual projects funded from an institution’s award will be of the order of £25k and approximately 6-12 months in length, although this will be dictated by the needs of each project. All projects should aim to be completed by 30 September 2021.
Competition format, deadlines, resubmissions
The deadline for applications is 23:59 Wednesday 6 May 2020. Applications will be reviewed by a panel comprising of University of Bristol staff.
Applicants will be informed of the outcome of their application within 4 weeks of the deadline. All proposals will receive feedback.
Applicants who have previously submitted an application for TRACK are eligible to resubmit if their proposal has been further developed since their original submission.
- These schemes are open to all University of Bristol academic staff members
- Funds will be used to support translational projects directly (not for coordination activities)
- Individual projects should be based on specific milestones in the translational pathway
The funding will not support:
- Entire translational projects; applicants seeking funding for entire projects are directed to Development Pathway Funding Scheme.
- Administration costs or industrial partner costs
- Staff between posts/funding (i.e. as “bridging” funds), or PhD studentships
- Continuation of normal research grants
- Costs relating to the protection of intellectual property
- Systematic literature reviews
Applications will be assessed on the following criteria:
- Is the health, clinical or product development need significant?
- Does the proposed solution have an advantage over competing solutions?
- What is the strength of the rationale and supporting evidence for why the proposed solution will meet the targeted need?
- Is the proposed workplan realistic?
- Will it answer the question or address the need identified?
- Does it offer good value for money?
- Does the team have the experience, skills and resources to deliver the planned work?
- Does the proposal make a convincing case that following the end of the award the project can be sustained to meet its ultimate aims?
- Is there an appropriate commercialisation plan in place to facilitate potential downstream exploitation (funding, partnering, commercialisation, etc)?
Terms and conditions
The funds awarded include contribution from our Wellcome Trust Institutional Strategic Support Fund and as such are covered by the Wellcome Trust terms and conditions (https://wellcome.ac.uk/funding/managing-grant/grant-conditions).
Please note that Clause 8.2 of the Wellcome Grant Conditions, related to Intellectual property (IP) and its exploitation, is waived in the context of this funding scheme. If you have any questions please contact EBI Manager Dr Nina Couzin firstname.lastname@example.org
How to apply
Download and complete the application form below, and return it to email@example.com by 23:59 Wednesday 6 May 2020.
Further information and queries
If you require further information or have any queries, please email Sarah Blackmore, EBI Funding Officer firstname.lastname@example.org
To discuss your project idea please contact email@example.com in the Research Enterprise & Development (RED) team.
Some examples of how this scheme works in practice:
- Richard Lee 'Novel targeting of disease causing cells could transform treatment of autoimmune diseases'
Further examples can be found on our Case studies page.
Funded TRACK projects
Find out more about our funded TRACK projects.